Design Therapeutics (DSGN) Leases (2021 - 2026)

Design Therapeutics' Leases history runs 6 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Leases rose 26.74% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (up 26.74% YoY), while the FY2025 annual figure was $1.4 million, down 35.11% from the prior year.
• Leases came in at $2.6 million for Q1 2026 at Design Therapeutics, up from $1.4 million in the prior quarter.
• In the past five years, Leases ranged from a high of $3.9 million in Q2 2022 to a low of $1.4 million in Q4 2025.
• A 5-year average of $2.8 million and a median of $2.8 million in 2024 frame the typical range for Leases.
• Across the five-year window, Leases slumped 35.11% in 2025 and grew 26.74% in 2026, its largest moves.
• Design Therapeutics' Leases stood at $3.6 million in 2022, then retreated by 18.66% to $2.9 million in 2023, then dropped by 24.57% to $2.2 million in 2024, then plunged by 35.11% to $1.4 million in 2025, then surged by 78.65% to $2.6 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $2.6 million, $1.4 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison